Michael Samuel, MD

Dr. Samuel is a nationally renowned clinician, surgeon, and researcher. Dr. Samuel specializes in the diagnosis and treatment of various retinal diseases, including diabetic retinopathy, age-related macular degeneration, macular hole, epiretinal membrane, and retinal vascular diseases.

Following his fellowships, Dr. Samuel accepted an academic position at Wills Eye Institute in Philadelphia, an internationally recognized eye hospital. He was a member of the Retina Service and an Assistant Professor of Ophthalmology for three years. Here, Dr. Samuel trained numerous residents and retina fellows in surgical and medical retinal diseases in one of the largest and most highly regarded programs in the nation.

He is consistently named as one of the “Top Doctors in the USA” and has won numerous surgical teaching awards. Along with Dr. Tom Chang, Dr. Samuel was part of the team that performed the world’s first surgical implantation of stem cell treatment for dry macular degeneration, which was in collaboration with the Johnson & Johnson Stem Cell organization. He also serves as the chairman of the executive committee of the Retina Institute.